IDH2 and central nervous system cancer: In a number of studies on glioma subtype clustering and risk group prediction, e.g., [34,70,74,75,91], the authors used retrospective datasets but additionally assessed associations of subgroups with IDH mutation and 1p/19q codeletion status.